ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS
· Delayed Price · Currency is USD
0.1508
+0.0006 (0.40%)
At close: Aug 14, 2025
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.22 million as of August 15, 2025. Its market cap has decreased by -57.74% in one year.
Market Cap
1.22M
Enterprise Value
1.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.22M, a decrease of -98.72%. That is a compound annual growth rate of -71.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 1.25M | -52.97% |
Dec 31, 2024 | 2.66M | -43.66% |
Dec 29, 2023 | 4.72M | -66.90% |
Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.93M |
Veradigm | 781.22M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 606.72M |
Elite Pharmaceuticals | 567.29M |
American Oncology Network | 389.51M |
Northwest Biotherapeutics | 351.78M |
CytoDyn | 336.73M |